HR Execs on the Move

BLM GROUP USA

www.blmgroup.com

 
BLM GROUP USA is a Wixom, MI-based company in the Manufacturing sector.
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Flex Roofing Systems

Flex Roofing Systems is a Leesport, PA-based company in the Manufacturing sector.

Bevi

Bevi is a smart water cooler that is becoming a fast favorite among millennial employees by offering a more fun and eco-friendly way of drinking beverages in the workplace. The company was founded in 2013 by MIT and Yale graduates who shared a sustainable vision to provide any beverage without needing a disposable bottle.

Bent River Machine Inc

Bent River Machine Inc is a Clarkdale, AZ-based company in the Manufacturing sector.

M Ward Manufacturing Inc

M Ward Manufacturing Inc is a Evanston, IL-based company in the Manufacturing sector.

enVVeno

enVVeno Medical (NASDAQ:NVNO) is an Irvine, California-based, late clinical-stage medical device company focused on the advancement of innovative bioprosthetic (tissue-based) solutions to improve the standard of care for the treatment of venous disease. The Company`s lead product, the VenoValve®, is a first-in-class surgical replacement venous valve being developed for the treatment of deep venous Chronic Venous Insufficiency (CVI). The Company is also developing a non-surgical, transcatheter based replacement venous valve for the treatment of deep venous CVI called enVVe™. CVI occurs when valves inside of the veins of the leg become damaged, resulting in the backwards flow of blood (reflux), blood pooling in the lower leg, increased pressure in the veins of the leg (venous hypertension) and in severe cases, venous ulcers that are difficult to heal and become chronic. Both the VenoValve and enVVe are designed to act as one-way valves, to help assist in propelling blood up the leg, and back to the heart and lungs. The VenoValve is currently being evaluated in the SAVVE U.S. pivotal study and the company is currently waiting for regulatory approval to begin the TAVVE first-in-human trial for enVVe.